Wright Medical Group Inc stock P/B Ratio (=5.16) is close to 10-year high of 5.16
The historical rank and industry rank for Wright Medical Group's PB Ratio or its related term are showing as below:
FRA:WM3'
s PB Ratio Range Over the Past 10 Years
Min: 1.04 Med: 2.35 Max: 5.16
Current: 5.16
During the past 13 years, Wright Medical Group's highest PB Ratio was 5.16. The lowest was 1.04. And the median was 2.35.
FRA:WM3's PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.235
vs FRA:WM3: 5.16
During the past 12 months, Wright Medical Group's average Book Value Per Share Growth Rate was -43.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -21.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Wright Medical Group was 8.80% per year. The lowest was 0.00% per year. And the median was 3.90% per year.
Back to Basics: PB Ratio
Wright Medical Group PB Ratio Historical Data
The historical data trend for Wright Medical Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Wright Medical Group's PB Ratio
For the Medical Devices subindustry, Wright Medical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wright Medical Group's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Wright Medical Group's PB Ratio falls into.
Wright Medical Group PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Wright Medical Group (FRA:WM3) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Wright Medical Group PB Ratio Related Terms
Thank you for viewing the detailed overview of Wright Medical Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Wright Medical Group (FRA:WM3) Business Description
Wright Medical Group Inc, through Wright Medical Technology, Inc. and other operating subsidiaries, is a specialty orthopaedic company, that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. The Company provides surgical solutions for the foot and ankle market and markets its products in over 60 countries. Its business includes products that are used in foot and ankle repair, upper extremity products, and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Extremity hardware includes implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow and shoulder, which it generally refer to as either foot and ankle or upper extremity products. The Company's manufacturing and warehousing operations are located in Arlington, Tennessee. Outside the U.S., The Company has distribution and administrative facilities in Amsterdam, the Netherlands, and sales and distribution offices in Canada, Australia, and Europe. The Company operates its continuing operations as one reportable segment and offer products in extremity reconstruction and biologics. The Company's products include CHARLOTTE, CLAW II, DARCO, EVOLVE, MICRONAIL, GRAFTJACKET, OSTEOSET. Its competitors include major companies in the orthopaedic and biologics industries, as well as academic institutions and other public and private research organizations that continue to conduct research, seek patent protection and establish arrangements for commercializing products. The Company's products are strictly regulated by the FDA under the Food, Drug, and Cosmetic Act. Some of its products are also regulated by state agencies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:WM3 has been successfully added to your 